Armored AutoGroup 10-Q 7 May 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2014	1-May-14
Document and Entity Information	'	'
Entity Registrant Name	'Armored AutoGroup Inc.	'
Entity Central Index Key	'0001537660	'
Document Type	'10-Q	'
Document Period End Date	31-Mar-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Entity Current Reporting Status	'Yes	'
Entity Filer Category	'Non-accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	1,000
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash	$13,182	$21,253
Accounts receivable, net	80,940	62,210
Inventories	36,629	34,043
Other current assets	7,400	9,790
Total current assets	138,151	127,296
Property, plant and equipment, net	27,559	28,936
Goodwill	357,507	358,826
Intangible assets, net	303,654	313,470
Investment in affiliate	10,000	'
Deferred financing costs and other assets, net	3,352	3,719
Total assets	840,223	832,247
Current liabilities:	'	'
Accounts payable	21,233	8,128
Accrued expenses and other current liabilities	32,285	23,455
Current portion of long-term debt, less discount	79	71
Total current liabilities	54,383	32,490
Long-term debt, less discount and current portion	544,464	553,511
Other liability	2,500	2,500
Deferred income taxes	86,530	89,610
Total liabilities	687,877	678,111
Commitments and contingencies (Note 4)	'	'
Shareholder's Equity:	'	'
Common stock ($0.01 par value, one thousand shares authorized, one thousand shares issued and outstanding at March 31, 2014 and December 31, 2013, respectively)	'	'
Additional paid-in capital	261,067	261,040
Accumulated deficit	-98,880	-98,955
Accumulated other comprehensive loss	-9,841	-7,949
Total shareholder's equity	152,346	154,136
Total liabilities and shareholder's equity	840,223	832,247
Parent	'	'
Current liabilities:	'	'
Amount due to related party	695	745
Clorox	'	'
Current liabilities:	'	'
Amount due to related party	$91	$91

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, except Per Share data, unless otherwise specified
CONDENSED CONSOLIDATED BALANCE SHEETS	'	'
Common stock, par value (in dollars per share)	$0.01	$0.01
Common stock, shares authorized	1	1
Common stock, shares issued	1	1
Common stock, shares outstanding	1	1

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS	'	'
Net sales	$80,559	$74,413
Cost of products sold	41,654	40,485
Gross profit	38,905	33,928
Operating expenses:	'	'
Selling and administrative expenses	11,552	9,603
Advertising costs	5,405	3,573
Research and development costs	608	638
Amortization of acquired intangible assets	9,111	9,175
Total operating expenses	26,676	22,989
Operating profit	12,229	10,939
Non-operating expenses:	'	'
Interest expense	11,949	11,906
Other (income) expense, net	-421	112
Income (loss) before benefit for income taxes	701	-1,079
Expense (benefit) for income taxes	-627	-573
Net income (loss)	74	-506
Other comprehensive loss:	'	'
Foreign currency translation	-1,892	-1,760
Comprehensive loss	($1,818)	($2,266)

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:	'	'
Net income (loss)	$74	($506)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:	'	'
Depreciation and amortization	11,919	11,883
Share-based compensation	27	65
Deferred income taxes	-3,098	-3,332
Other	2	'
Cash effect of changes in:	'	'
Accounts receivable, net	-18,730	-5,863
Inventories	-2,586	-2,933
Prepaid Taxes	2,830	2,022
Other current assets	-451	-1,846
Accounts payable and accrued liabilities	21,936	8,787
Due to Clorox	'	-31
Other	102	-49
Net cash provided by operating activities	12,025	8,197
Cash flows from investing activities:	'	'
Capital expenditures	-328	-944
Investment in affiliate	-10,000	'
Net cash used in investing activities	-10,328	-944
Cash flows from financing activities:	'	'
Principal payments on term loan	-9,750	-750
Payment on advance from Parent	-50	'
Net cash used in financing activities	-9,800	-750
Effect of exchange rate changes on cash	32	1
Net (decrease) increase in cash	-8,071	6,504
Cash at beginning of period	21,253	4,206
Cash at end of period	13,182	10,710
Supplemental cash flow disclosures:	'	'
Cash paid for interest	4,695	4,679
Cash paid for income taxes	$555	$737

The_Company_and_Summary_of_Sig

The Company and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2014
The Company and Summary of Significant Accounting Policies	'
The Company and Summary of Significant Accounting Policies	'
	Note 1 — The Company and Summary of Significant Accounting Policies
	The Company
	Armored AutoGroup Inc. is a consumer products company consisting primarily of Armor All® and STP®, two of the most recognizable brands in the automotive aftermarket appearance products and performance chemicals categories, respectively. Armored AutoGroup delivers its products to distributors, resellers and end customers (collectively the customers) through its direct operations in the United States, Canada, Mexico, Australia, China and the United Kingdom and distributor relationships in approximately 50 countries. The Armor All and STP brands offer multiple automotive appearance and performance chemical products that can be found in most of the major developed countries around the world.
	In September 2010, Viking Acquisition Inc., an entity owned by affiliates of Avista Capital Holdings, L.P. (“Avista”), entered into an agreement to acquire the AutoCare Products Business, Armor All, STP and certain other brands from The Clorox Company (“Clorox”) pursuant to the terms of a Purchase and Sale Agreement dated September 21, 2010 (the “Acquisition”).  The Acquisition closed on November 5, 2010 and included employees in the United States and other countries dedicated to the Company, related product patent and developed technology and certain other assets, including the manufacturing facilities located in Painesville, Ohio and Wales, U.K. Viking Acquisition Inc. was subsequently renamed Armored AutoGroup Inc. (“AAG”).  Armored AutoGroup Parent Inc. (“AAG Parent” or “Parent”) indirectly owns all of AAG’s issued and outstanding capital stock through its direct subsidiary and AAG’s direct parent, Armored AutoGroup Intermediate Inc. (“Intermediate”).
	Basis of Presentation
	The interim condensed consolidated financial statements for the three month periods ended March 31, 2014 and 2013 are unaudited but, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of the Company for the periods presented. The preparation of these financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures. Actual results could differ materially from the estimates and assumptions made. Further, the results for the interim period ended March 31, 2014 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2014, or for any future period.
	The Company’s business is moderately seasonal and can be impacted by weather. Sales are typically higher in the first half of the calendar year as the Company’s customers in the northern hemisphere purchase inventory for the spring and summer seasons when weather is warmer than in the fall and winter months.  This pattern is largely reflective of our customers’ seasonal purchasing patterns, as well as the timing of our promotional activities. Weather can also influence consumer behavior, especially for appearance products. Our appearance products sell best during warm, dry weather, and less if weather is cold and wet.  For these reasons, among others, the Company’s results for any quarter are not necessarily indicative of future quarterly results and, accordingly, period-to-period comparisons should not be relied upon as an indication of future performance.
	Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted or condensed pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The information in this report should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the SEC for the fiscal year ended December 31, 2013, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies. The consolidated balance sheet at December 31, 2013 has been derived from the Company’s audited financial statements at that date, but does not include all of the financial information or disclosures required by U.S. GAAP for complete financial statements.
	Revenue Recognition
	Sales are recognized when title to the product, ownership and risk of loss transfer to the customer, which can be on the date of shipment or the date of receipt by the customer and when all of the following have occurred: a firm sales arrangement exists, pricing is fixed and determinable, and collection is reasonably assured. Revenue includes shipping and handling costs, which generally are included in the list price to the customer. Taxes collected from customers and remitted to governmental authorities are not included in sales. A provision for payment discounts and product return allowances is recorded as a reduction of sales in the same period that the revenue is recognized.
	The Company routinely commits to trade promotion programs with customers, consisting primarily of customer pricing allowances, merchandising funds and consumer coupons offered through various programs to customers and consumers. Accruals for expected payouts under these programs are included as accrued marketing and promotion in the accrued expenses and other current liabilities line item in the Condensed Consolidated Balance Sheets and are recorded as a reduction of sales in the Condensed Statements of Comprehensive Loss.
	Amounts received by the Company from the licensing of certain trademarks are recorded as deferred revenue in the Condensed Consolidated Balance Sheets and are recognized as revenue on a straight-line basis over the term of the licensing agreement when the underlying royalties are earned.
	Cost of Products Sold
	Cost of products sold is primarily comprised of direct materials and supplies consumed in the manufacturing of product, as well as manufacturing labor, depreciation expense, direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product, contract manufacturing costs, and provisions for inventory losses (including losses relating to excess and obsolete inventory). Cost of products sold also includes the cost to distribute products to customers, inbound freight costs, internal transfer costs, warehousing costs and other shipping and handling activity as well as costs associated with developing and designing new packaging.
	Income Taxes
	The Company uses the asset and liability method to account for income taxes. For purposes of the unaudited interim condensed consolidated financial statements, the Company calculates tax with reference to the anticipated effective tax rate for the annual financial period. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to the differences between the financial statement amounts and their respective tax bases. Management reviews the Company’s deferred tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established when management believes that it is more likely than not that some portion or all of its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company’s tax provision in the period of change. In addition to valuation allowances, the Company provides for uncertain tax positions when such tax positions do not meet the recognition thresholds or measurement standards prescribed by accounting guidance on the accounting for uncertainty in income taxes. Amounts for uncertain tax positions are adjusted when new information becomes available or when positions are effectively settled.
	None of the Company’s goodwill is expected to be deductible for tax purposes.
	The Company files a consolidated federal and certain state income tax returns with its Parent.  Income taxes have been prepared on a separate return basis.  The Company pays its tax liability on behalf of its Parent.
	Foreign Currency Translation
	Local currencies are the functional currencies for substantially all of the Company’s foreign operations. When the transactional currency is different than the functional currency, transaction gains and losses are included as a component of other (income) expense, net.  Assets and liabilities of foreign operations are translated into U.S. dollars using the exchange rates in effect at the respective balance sheet reporting date. Income and expenses are translated at the average exchange rate during the period. Gains and losses on foreign currency translation are reported as a component of accumulated other comprehensive (loss) income. Deferred taxes are not provided on cumulative translation adjustments where the Company expects earnings of a foreign subsidiary to be indefinitely reinvested.
	Goodwill and Intangible Assets
	The Company tests its goodwill and trademark and brand intangible assets with indefinite lives annually as of October 1st unless there are indications during an interim period that these assets may have become impaired.  Goodwill impairment occurs when the carrying amount of one of the Company’s reporting unit’s goodwill exceeds its implied fair value. The Company would then record an impairment charge being the difference between the carrying amount and the implied fair value of the reporting unit’s goodwill. For trademarks and brand intangible assets with indefinite lives, impairment occurs when the carrying amount of an asset is greater than its estimated fair value and an impairment charge is recorded for the difference between the carrying amount and the fair value. The Company’s estimates of fair value are based primarily on a discounted cash flow approach as supplemented by a market based approach. Significant judgment is necessary in the preparation of assumptions and estimates inherent in such valuation approaches, particularly with respect to the determination of future volumes, revenue and expense growth rates, changes in working capital use, foreign-exchange rates, inflation, the selection of an appropriate discount rate and the calculation of an average earnings before interest, tax, depreciation and amortization (“EBITDA”) multiple of a selected public-company peer group. In particular, the discount rates the Company utilizes in these analyses, as well as expectations for future cash flows, may be influenced by such factors as changes in interest rates, rates of inflation and changes in regional risk.  During the three months ended March 31, 2014, goodwill decreased by $1.3 million due to currency translation.
	Property, Plant & Equipment and Finite-Lived Intangible Assets
	Property, plant and equipment and finite-lived intangible assets are stated at cost less accumulated depreciation and amortization. The Company calculates depreciation and amortization expenses by the straight-line method using estimated useful lives of the related assets. The Company reviews property, plant and equipment and finite-lived intangible assets for impairment whenever events or changes in circumstances occur that indicate that the carrying amount of an asset or asset group may not be recoverable. The Company’s impairment review is based on an estimate of the undiscounted cash flows at the lowest level for which identifiable cash flows exist and impairment occurs when the book value of the asset group exceeds the estimated future undiscounted cash flows generated by the asset group. When impairment is indicated, a charge is recorded for the difference between the book value of the asset group and its fair value. Depending on the asset or asset group, estimated fair value may be determined either by use of a discounted cash flow model or by reference to estimated selling values of assets in a similar condition.
	Recent Accounting Pronouncements
	The Company adopted the following pronouncements effective January 1, 2014:
	In February 2013 the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) No. 2013-04—Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date (ASU 2013-04). The ASU requires reporting and disclosure about obligations resulting from joint and several liability arrangements within its scope for which the total amount of the obligation is fixed at the reporting date. For the Company, ASU 2013-04 is effective January 1, 2014 for fiscal year 2014 and interim periods therein. The guidance in ASU 2013-04 is to be applied retrospectively for those obligations resulting from joint and several liability arrangements within its scope that exist at January 1, 2014. Adoption of ASU 2013-04 did not have a material impact on the Company.

Inventories

Inventories	3 Months Ended
	Mar. 31, 2014
Inventories	'
Inventories	'
	Note 2 — Inventories
	Inventories consisted of the following (in thousands):
		March 31,			December 31,
		2014			2013
	Finished goods	$	29,285		$	28,400
	Raw materials and packaging	9,724			7,896
	Allowances for obsolescence	(2,380		)	(2,253		)
		$	36,629		$	34,043

Fair_Value_Measurement_of_Asse

Fair Value Measurement of Assets and Liabilities	3 Months Ended
	Mar. 31, 2014
Fair Value Measurement of Assets and Liabilities	'
Fair Value Measurement of Assets and Liabilities	'
	Note 3 — Fair Value Measurement of Assets and Liabilities
	The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value which is intended to increase consistency and comparability and related disclosures. An asset or liability’s classification is based on the lowest level of input that is significant to the fair value measurement and is disclosed in one of the following three categories:
	Level 1—Quoted market prices in active markets for identical assets or liabilities.
	Level 2—Observable market-based inputs or unobservable inputs that are corroborated by market data.
	Level 3—Unobservable inputs reflecting the reporting entity’s own assumptions.
	The Company’s financial instruments consist of cash, trade accounts receivable, trade accounts payable and long-term debt. Due to their short-term maturity, the carrying amounts of cash, trade accounts receivable and trade accounts payable approximate their fair market values. The carrying and fair values of the Company’s long-term debt were as follows (in thousands):
		March 31, 2014				December 31, 2013
		Carrying		Fair		Carrying		Fair
		Value		Value		Value		Value
	Term loan	$	276,637	$	281,953	$	285,982	$	291,000
	Senior notes	267,906		288,750		267,600		267,438
	The fair value of the Term Loan and the Senior Notes was determined using broker quotes, which use discounted cash flows, an income approach, and the then-applicable forward LIBOR rates and, therefore, meets the definition of Level 2 fair value, as defined above.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2014
Commitments and Contingencies	'
Commitments and Contingencies	'
	Note 4 — Commitments and Contingencies
	Litigation and Other Legal Matters
	In connection with the Acquisition, Clorox retained liability associated with a potential contract claim and the Company agreed to indemnify and reimburse Clorox for 50% of the first $5,000,000 in settlement costs related to the contract claim. As of March 31, 2014 and December 31, 2013, the Company has accrued $2,500,000 in long-term liabilities related to this contingency.
	The Company is subject to various lawsuits and claims relating to issues such as contract disputes, product liability, patents and trademarks, advertising, employee and other matters. Although the results of claims and litigation cannot be predicted with certainty, it is the opinion of management that the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, individually or in the aggregate, on the Company’s financial statements taken as a whole.

Income_taxes

Income taxes	3 Months Ended
	Mar. 31, 2014
Income taxes	'
Income taxes	'
	Note 5 — Income taxes
	The Company’s effective tax rate was as follows:
		Three months ended March 31,
		2014		2013
	Effective tax rate	89.4	%	53.1	%
	The Company’s effective tax rate for the three month period ended March 31, 2014 differs from the statutory tax rate primarily due to U.S. federal manufacturing benefits recognized and state taxes. Further, the Company’s effective tax rate has increased for the three month period ended March 31, 2014 as compared to the corresponding period in 2013 primarily as a result of a discrete tax charge of $0.4 million recorded during the three month period ending March 31, 2014.  The discrete tax charge is primarily the result of a change in the uncertain tax positions recorded by Clorox, for which the Company has recorded a corresponding benefit in income from operations due to the indemnification agreement between the entities.

Segment_Data

Segment Data	3 Months Ended
	Mar. 31, 2014
Segment Data	'
Segment Data	'
	Note 6 — Segment Data
	The Company manages its business through two geographic segments: North America and International.
	·                  North America—consists of auto-care products marketed and sold in the United States and Canada. Products within this segment include auto-care products primarily under the Armor All and STP brands.
	·                  International—consists of products sold outside North America, including Australia, Europe and other international locations. Products within this segment include auto-care products primarily under the Armor All and STP brands.
	The Company does not allocate its amortization of intangible assets or interest expense between its North America and International segments but includes them in the tables below under Corporate in order to reconcile the North America and International segments’ performance to the Company’s Condensed Consolidated Statements of Comprehensive Loss. All intersegment sales are eliminated and are not included in the Company’s reportable segments’ net sales.
	The following summarizes the financial performance of the Company’s operating segments (in thousands):
		Three Months Ended March 31, 2014
		North		International		Corporate			Consolidated
		America
	Net sales	$	61,567	$	18,992	$	—		$	80,559
	Earnings (loss) before income taxes	18,758		3,003		(21,060		)	701
	Capital expenditures	276		52		—			328
	Depreciation of property, plant and equipment and amortization of intangible assets	1,577		122		9,111			10,810
	Share based compensation	24		3		—			27
		Three Months Ended March 31, 2013
		North		International		Corporate			Consolidated
		America
	Net sales	$	56,614	$	17,799	$	—		$	74,413
	Earnings (loss) before income taxes	18,276		1,726		(21,081		)	(1,079		)
	Capital expenditures	793		151		—			944
	Depreciation of property plant and equipment and amortization of intangible assets	1,511		146		9,175			10,832
	Share based compensation	62		3		—			65

Financial_Information_for_the_

Financial Information for the Company and Its Subsidiaries	3 Months Ended
	Mar. 31, 2014
Financial Information for the Company and Its Subsidiaries	'
Financial Information for the Company and Its Subsidiaries	'
	Note 7 — Financial Information for the Company and Its Subsidiaries
	The Company’s payment obligations under the Senior Notes are guaranteed, jointly and severally, by all of the Company’s wholly owned domestic subsidiaries that guarantee the obligations of the Company under the Credit Facility. These guarantees are full and unconditional, subject, in the case of the subsidiary guarantors, to customary release provisions. The Company conducts substantially all of its business through its subsidiaries. In servicing payments to be made on the Senior Notes and other indebtedness, and to satisfy other liquidity requirements, the Company will rely, in large part, on cash flows from these subsidiaries, mainly in the form of dividends, royalties and advances or payments on account of intercompany loan arrangements. The ability of these subsidiaries to make dividend payments to the Company will be affected by, among other factors, the obligations of these entities to their creditors, requirements of corporate and other law, and restrictions contained in agreements entered into by or relating to these entities.
	The following supplemental condensed consolidating financial information sets forth balance sheets, statements of comprehensive (loss) income and statements of cash flows for the Company, the guarantor subsidiaries, the non-guarantor subsidiaries and elimination entries necessary to consolidate the Company and its subsidiaries. This information is presented in lieu of separate financial statements and other related disclosures pursuant to Regulation S-X Rule 3-10 of the Securities Exchange Act of 1934, as amended, “Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.”
	The operating and investing activities of the separate legal entities are fully interdependent and integrated. Accordingly, the results of the separate legal entities are not representative of what the operating results would be on a standalone basis.
	Condensed Consolidating Balance Sheet
	March 31, 2014
		Issuer			Combined			Combined			Eliminations			Consolidated
					Guarantor			Non-
					Subsidiaries			Guarantor
								Subsidiaries
	ASSETS
	Current assets:
	Cash	$	4,789		$	—		$	8,393		$	—		$	13,182
	Accounts receivable, net	6			63,100			17,834			—			80,940
	Inventories	—			26,716			9,913			—			36,629
	Other current assets	60,487			(54,367		)	1,280			—			7,400
	Total current assets	65,282			35,449			37,420			—			138,151
	Property, plant and equipment, net	7,823			17,078			2,658			—			27,559
	Goodwill	—			310,576			46,931			—			357,507
	Intangible assets, net	—			268,916			35,982			(1,244		)	303,654
	Investment in subsidiaries	627,915			113,737			—			(741,652		)	—
	Investment in affiliate	10,000			—			—			—			10,000
	Deferred financing costs and other assets, net	3,265			87			—			—			3,352
	Total assets	$	714,285		$	745,843		$	122,991		$	(742,896	)	$	840,223
	LIABILITIES AND SHAREHOLDER’S EQUITY
	Current liabilities:
	Accounts payable	$	786		$	16,255		$	4,192		$	—		$	21,233
	Accrued expenses and other current liabilities	16,981			10,283			5,021			—			32,285
	Due to Clorox	69			23			(1		)	—			91
	Due to Parent	695			—			—			—			695
	Current portion of long-term debt, less discount	79			—			—			—			79
	Total current liabilities	18,610			26,561			9,212			—			54,383
	Long-term debt, less discount and current portion	544,464			—			—			—			544,464
	Other liability	2,500			—			—			—			2,500
	Deferred income taxes	5,121			81,367			42			—			86,530
	Total liabilities	570,695			107,928			9,254			—			687,877
	Shareholder’s equity	143,590			637,915			113,737			(742,896		)	152,346
	Total liabilities and shareholder’s equity	$	714,285		$	745,843		$	122,991		$	(742,896	)	$	840,223
	Condensed Consolidating Balance Sheet
	Year Ended December 31, 2013
		Issuer			Combined			Combined			Eliminations			Consolidated
					Guarantor			Non-						Total
					Subsidiaries			Guarantor
								Subsidiaries
	ASSETS
	Current assets:
	Cash	$	14,843		$	—		$	6,410		$	—		$	21,253
	Accounts receivable	78			44,885			17,247			—			62,210
	Inventory	—			24,553			9,490			—			34,043
	Other current assets	53,853			(45,072		)	1,009			—			9,790
	Total current assets	68,774			24,366			34,156			—			127,296
	Property, plant and equipment	8,061			18,037			2,838			—			28,936
	Goodwill	—			310,576			48,250			—			358,826
	Intangible assets	—			276,461			38,198			(1,189		)	313,470
	Investment in subsidiaries	647,107			115,394			—			(762,501		)	—
	Other assets	3,632			87			—			—			3,719
	Total assets	$	727,574		$	744,921		$	123,442		$	(763,690	)	$	832,247
	LIABILITIES AND SHAREHOLDER’S EQUITY
	Current liabilities:
	Accounts payable	$	169		$	5,103		$	2,856		$	—		$	8,128
	Accrued expenses and other current liabilities	10,063			8,263			5,129			—			23,455
	Due to Clorox	69			23			(1		)	—			91
	Due to Parent	745			—			—			—			745
Notes payable, current portion	71			—			—			—			71
Total current liabilities	11,117			13,389			7,984						32,490
Notes payable, less current portion and discount	553,511			—			—			—			553,511
Other liabilities	2,500			—			—			—			2,500
Deferred income taxes	5,121			84,425			64			—			89,610
Total liabilities	572,249			97,814			8,048			—			678,111
Shareholder’s equity	155,325			647,107			115,394			(763,690		)	154,136
Total liabilities and shareholder’s equity	$	727,574		$	744,921		$	123,442		$	(763,690	)	$	832,247
Condensed Consolidating Statement of Comprehensive Income (Loss)
Three months ended March 31, 2014
	Issuer			Combined			Combined			Eliminations			Consolidated
				Guarantor			Non-
				Subsidiaries			Guarantor
							Subsidiaries
Net sales	$	—		$	66,428		$	20,359		$	(6,228	)	$	80,559
Cost of products sold	—			33,765			14,117			(6,228		)	41,654
Gross profit	—			32,663			6,242			—			38,905
Operating expenses:
Selling and administrative expenses	5,729			2,941			2,882			—			11,552
Advertising costs	—			3,924			1,481			—			5,405
Research and development costs	—			608			—			—			608
Amortization of acquired intangible assets	—			7,545			1,566			—			9,111
Total operating expenses	5,729			15,018			5,929			—			26,676
Operating (loss) profit	(5,729		)	17,645			313			—			12,229
Non-operating expenses:
Interest expense	11,949			—			—			—			11,949
Other expense, net	(425		)	—			4			—			(421		)
(Loss) earnings before (benefit) provision for income taxes	(17,253		)	17,645			309			—			701
(Benefit) provision for income taxes	(6,406		)	6,775			258			—			627
Equity earnings (loss) of subsidiaries, net of taxes	10,921			51			—			(10,972		)	—
Net (loss) earnings	$	74		$	10,921		$	51		$	(10,972	)	$	74
Other comprehensive loss:
Foreign currency translation	(1,892		)	(1,892		)	(1,892		)	3,784			(1,892		)
Comprehensive loss	$	(1,818	)	$	9,029		$	(1,841	)	$	(7,188	)	$	(1,818	)
Condensed Consolidating Statement of Comprehensive (Loss) Income
Three months ended March 31, 2013
							Combined
				Combined			Non-
				Guarantor			Guarantor
	Issuer			Subsidiaries			Subsidiaries			Eliminations			Consolidated
Net sales	$	—		$	61,797		$	18,606		$	(5,990	)	$	74,413
Cost of products sold	—			34,238			12,237			(5,990		)	40,485
Gross profit	—			27,559			6,369			—			33,928
Operating expenses:
Selling and administrative expenses	4,300			2,742			2,561			—			9,603
Advertising costs	—			2,099			1,474			—			3,573
Research and development costs	—			638			—			—			638
Amortization of acquired intangible assets	—			7,545			1,630			—			9,175
Total operating expenses	4,300			13,024			5,665			—			22,989
Operating (loss) profit	(4,300		)	14,535			704			—			10,939
Non-operating expenses:
Interest expense	11,906			—			—			—			11,906
Other expense, net	—			4			108			—			112
(Loss) earnings before income taxes	(16,206		)	14,531			596			—			(1,079		)
(Benefit) provision for income taxes	(6,103		)	5,373			157			—			(573		)
Equity earnings of subsidiaries, net of taxes	9,597			439			—			(10,036		)	—
Net (loss) earnings	$	(506	)	$	9,597		$	439		$	(10,036	)	$	(506	)
Other comprehensive (loss) income:
Foreign currency translation	(1,760		)	(1,760		)	(1,760		)	3,520			(1,760		)
Comprehensive (loss) income	$	(2,266	)	$	7,837		$	(1,321	)	$	(6,516	)	$	(2,266	)
Condensed Consolidating Statement of Cash Flows
Three months ended March 31, 2014
	Issuer			Combined			Combined			Eliminations			Consolidated
				Guarantor			Non-
				Subsidiaries			Guarantor
							Subsidiaries
Cash flows from operating activities:
Net (loss) earnings	$	74		$	10,921		$	51		$	(10,972	)	$	74
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	1,550			8,577			1,792			—			11,919
Share-based compensation	27			—			—			—			27
Deferred income taxes	(16		)	(3,060		)	(22		)	—			(3,098		)
Equity earnings of subsidiaries, net of taxes	(10,921		)	(51		)	—			10,972			—
Other	—			—			2			—			2
Cash effect of changes in:
Accounts receivable, net	72			(18,215		)	(587		)	—			(18,730		)
Inventories	—			(2,163		)	(423		)	—			(2,586		)
Prepaid taxes	(6,432		)	9,262						—			2,830
Other current assets	(216		)	34			(269		)	—			(451		)
Accounts payable and accrued liabilities	7,537			13,171			1,228			—			21,936
Intercompany and other	18,277			(18,406		)	231			—			102
Net cash provided by operating activities:	9,952			70			2,003			—			12,025
Cash flows from investing activities:
Capital expenditures	(206		)	(70		)	(52		)	—			(328		)
Acquisition, net	(10,000		)	—			—			—			(10,000		)
Net cash used in investing activities	(10,206		)	(70		)	(52		)	—			(10,328		)
Cash flows from financing activities:
Principal payments on term loan	(9,750		)	—			—			—			(9,750		)
Payment of advance from Parent	(50		)	—			—			—			(50		)
Net cash used in by financing activities	(9,800		)	—			—			—			(9,800		)
Effect of exchange rate changes on cash	—			—			32			—			32
Net increase in cash	(10,054		)	—			1,983			—			(8,071		)
Cash at beginning of period	14,843			—			6,410			—			21,253
Cash at end of period	$	4,789		$	—		$	8,393		$	—		$	13,182
Condensed Consolidating Statement of Cash Flows
Three months ended March 31, 2013
							Combined
				Combined			Non-
				Guarantor			Guarantor
	Issuer			Subsidiaries			Subsidiaries			Eliminations			Consolidated
Cash flows from operating activities:
Net (loss) earnings	$	(506	)	$	9,597		$	439		$	(10,036	)	$	(506	)
Adjustments:
Depreciation and amortization	1,493			8,593			1,797			—			11,883
Share-based compensation	65			—			—			—			65
Deferred income taxes	—			(3,648		)	316			—			(3,332		)
Equity earnings of subsidiaries, net of taxes	(9,597		)	(439		)	—			10,036			—
Cash effect of changes in:
Accounts receivable	34			(8,225		)	2,328			—			(5,863		)
Inventories	—			(2,200		)	(733		)	—			(2,933		)
Prepaid taxes	1,940			—			82			—			2,022
Other current assets	485			(2,391		)	60			—			(1,846		)
Accounts payable and accrued liabilities	3,964			7,682			(2,859		)	—			8,787
Due from Clorox	—			—			(31		)	—			(31		)
Intercompany and other	3,637			(8,176		)	4,490			—			(49		)
Net cash (used in) provided by operating activities	1,515			793			5,889			—			8,197
Cash flows from investing activities:
Capital expenditures	—			(793		)	(151		)	—			(944		)
Net cash used in investing activities	—			(793		)	(151		)	—			(944		)
Cash flows from financing activities:
Principal payments on term loan	(750		)	—			—			—			(750		)
Net cash provided by financing activities	(750		)	—			—			—			(750		)
Effect of exchange rate on cash							1						1
Net increase (decrease) in cash	765			—			5,739			—			6,504
Cash at beginning of period	1,477			—			2,729			—			4,206
Cash at end of period	$	2,242		$	—		$	8,468		$	—		$	10,710

Investment_in_Affiliate

Investment in Affiliate	3 Months Ended
	Mar. 31, 2014
Investment in Affiliate	'
Investment in Affiliate	'
	Note 8 — Investment in Affiliate
	On March 17, 2014, the Company paid $10.0 million to acquire a non-controlling equity interest in IDQ Acquisition Corp. (“IDQ”) and also paid $1.2 million in transaction fees and closing costs.  The investment is accounted for under the cost method of accounting.  The Company did not evaluate the investment for impairment due the limited holding time period.  The transaction fees and closing costs included $0.3 million paid to a board member for services rendered in connection with the transaction.  The transaction fees and closing costs are reported in selling and administrative expenses on the Condensed Consolidated Statements of Comprehensive Loss.  On the same date, Parent acquired a controlling equity interest in IDQ.  In connection with the investment, the Company entered into a Shared Services and Supply Agreement (the “Shared Services Agreement”) with IDQ and Parent pursuant to which certain products and services will be provided on an arm’s-length basis by one party to another, as agreed by the Company and IDQ, with the purpose of utilizing the assets and operations of each company to increase sales and lower the combined costs for the mutual benefit of both IDQ and us.  On March 11, 2014, the Company entered into an amendment of its Credit Facility revising a defined term, Consolidated EBITDA.  Consolidated EBITDA is used in the calculation of certain financial condition covenants under the Credit Facility.  The revision to the definition of Consolidated EBITDA excludes from Consolidated EBITDA fees and expenses incurred for the Company’s investment in IDQ Acquisition Corp., the Company’s implementation of a management services agreement with IDQ Acquisition Corp. and the Company’s pursuit of cost savings, expense reductions and other operating improvements and synergies related to IDQ.

The_Company_and_Summary_of_Sig1

The Company and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2014
The Company and Summary of Significant Accounting Policies	'
Basis of Presentation	'
	Basis of Presentation
	The interim condensed consolidated financial statements for the three month periods ended March 31, 2014 and 2013 are unaudited but, in the opinion of management, reflect all adjustments (consisting of normal recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows of the Company for the periods presented. The preparation of these financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect reported amounts and related disclosures. Actual results could differ materially from the estimates and assumptions made. Further, the results for the interim period ended March 31, 2014 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2014, or for any future period.
	The Company’s business is moderately seasonal and can be impacted by weather. Sales are typically higher in the first half of the calendar year as the Company’s customers in the northern hemisphere purchase inventory for the spring and summer seasons when weather is warmer than in the fall and winter months.  This pattern is largely reflective of our customers’ seasonal purchasing patterns, as well as the timing of our promotional activities. Weather can also influence consumer behavior, especially for appearance products. Our appearance products sell best during warm, dry weather, and less if weather is cold and wet.  For these reasons, among others, the Company’s results for any quarter are not necessarily indicative of future quarterly results and, accordingly, period-to-period comparisons should not be relied upon as an indication of future performance.
	Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted or condensed pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The information in this report should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the SEC for the fiscal year ended December 31, 2013, which includes a complete set of footnote disclosures, including the Company’s significant accounting policies. The consolidated balance sheet at December 31, 2013 has been derived from the Company’s audited financial statements at that date, but does not include all of the financial information or disclosures required by U.S. GAAP for complete financial statements.
Revenue Recognition	'
	Revenue Recognition
	Sales are recognized when title to the product, ownership and risk of loss transfer to the customer, which can be on the date of shipment or the date of receipt by the customer and when all of the following have occurred: a firm sales arrangement exists, pricing is fixed and determinable, and collection is reasonably assured. Revenue includes shipping and handling costs, which generally are included in the list price to the customer. Taxes collected from customers and remitted to governmental authorities are not included in sales. A provision for payment discounts and product return allowances is recorded as a reduction of sales in the same period that the revenue is recognized.
	The Company routinely commits to trade promotion programs with customers, consisting primarily of customer pricing allowances, merchandising funds and consumer coupons offered through various programs to customers and consumers. Accruals for expected payouts under these programs are included as accrued marketing and promotion in the accrued expenses and other current liabilities line item in the Condensed Consolidated Balance Sheets and are recorded as a reduction of sales in the Condensed Statements of Comprehensive Loss.
	Amounts received by the Company from the licensing of certain trademarks are recorded as deferred revenue in the Condensed Consolidated Balance Sheets and are recognized as revenue on a straight-line basis over the term of the licensing agreement when the underlying royalties are earned.
Cost of Products Sold	'
	Cost of Products Sold
	Cost of products sold is primarily comprised of direct materials and supplies consumed in the manufacturing of product, as well as manufacturing labor, depreciation expense, direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product, contract manufacturing costs, and provisions for inventory losses (including losses relating to excess and obsolete inventory). Cost of products sold also includes the cost to distribute products to customers, inbound freight costs, internal transfer costs, warehousing costs and other shipping and handling activity as well as costs associated with developing and designing new packaging.
Income Taxes	'
	Income Taxes
	The Company uses the asset and liability method to account for income taxes. For purposes of the unaudited interim condensed consolidated financial statements, the Company calculates tax with reference to the anticipated effective tax rate for the annual financial period. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to the differences between the financial statement amounts and their respective tax bases. Management reviews the Company’s deferred tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established when management believes that it is more likely than not that some portion or all of its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company’s tax provision in the period of change. In addition to valuation allowances, the Company provides for uncertain tax positions when such tax positions do not meet the recognition thresholds or measurement standards prescribed by accounting guidance on the accounting for uncertainty in income taxes. Amounts for uncertain tax positions are adjusted when new information becomes available or when positions are effectively settled.
	None of the Company’s goodwill is expected to be deductible for tax purposes.
	The Company files a consolidated federal and certain state income tax returns with its Parent.  Income taxes have been prepared on a separate return basis.  The Company pays its tax liability on behalf of its Parent.
Foreign Currency Translation	'
	Foreign Currency Translation
	Local currencies are the functional currencies for substantially all of the Company’s foreign operations. When the transactional currency is different than the functional currency, transaction gains and losses are included as a component of other (income) expense, net.  Assets and liabilities of foreign operations are translated into U.S. dollars using the exchange rates in effect at the respective balance sheet reporting date. Income and expenses are translated at the average exchange rate during the period. Gains and losses on foreign currency translation are reported as a component of accumulated other comprehensive (loss) income. Deferred taxes are not provided on cumulative translation adjustments where the Company expects earnings of a foreign subsidiary to be indefinitely reinvested.
Goodwill and Intangible Assets	'
	Goodwill and Intangible Assets
	The Company tests its goodwill and trademark and brand intangible assets with indefinite lives annually as of October 1st unless there are indications during an interim period that these assets may have become impaired.  Goodwill impairment occurs when the carrying amount of one of the Company’s reporting unit’s goodwill exceeds its implied fair value. The Company would then record an impairment charge being the difference between the carrying amount and the implied fair value of the reporting unit’s goodwill. For trademarks and brand intangible assets with indefinite lives, impairment occurs when the carrying amount of an asset is greater than its estimated fair value and an impairment charge is recorded for the difference between the carrying amount and the fair value. The Company’s estimates of fair value are based primarily on a discounted cash flow approach as supplemented by a market based approach. Significant judgment is necessary in the preparation of assumptions and estimates inherent in such valuation approaches, particularly with respect to the determination of future volumes, revenue and expense growth rates, changes in working capital use, foreign-exchange rates, inflation, the selection of an appropriate discount rate and the calculation of an average earnings before interest, tax, depreciation and amortization (“EBITDA”) multiple of a selected public-company peer group. In particular, the discount rates the Company utilizes in these analyses, as well as expectations for future cash flows, may be influenced by such factors as changes in interest rates, rates of inflation and changes in regional risk.  During the three months ended March 31, 2014, goodwill decreased by $1.3 million due to currency translation.
Property, Plant & Equipment and Finite-Lived Intangible Assets	'
	Property, Plant & Equipment and Finite-Lived Intangible Assets
	Property, plant and equipment and finite-lived intangible assets are stated at cost less accumulated depreciation and amortization. The Company calculates depreciation and amortization expenses by the straight-line method using estimated useful lives of the related assets. The Company reviews property, plant and equipment and finite-lived intangible assets for impairment whenever events or changes in circumstances occur that indicate that the carrying amount of an asset or asset group may not be recoverable. The Company’s impairment review is based on an estimate of the undiscounted cash flows at the lowest level for which identifiable cash flows exist and impairment occurs when the book value of the asset group exceeds the estimated future undiscounted cash flows generated by the asset group. When impairment is indicated, a charge is recorded for the difference between the book value of the asset group and its fair value. Depending on the asset or asset group, estimated fair value may be determined either by use of a discounted cash flow model or by reference to estimated selling values of assets in a similar condition.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	The Company adopted the following pronouncements effective January 1, 2014:
	In February 2013 the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) No. 2013-04—Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date (ASU 2013-04). The ASU requires reporting and disclosure about obligations resulting from joint and several liability arrangements within its scope for which the total amount of the obligation is fixed at the reporting date. For the Company, ASU 2013-04 is effective January 1, 2014 for fiscal year 2014 and interim periods therein. The guidance in ASU 2013-04 is to be applied retrospectively for those obligations resulting from joint and several liability arrangements within its scope that exist at January 1, 2014. Adoption of ASU 2013-04 did not have a material impact on the Company.

Inventories_Tables

Inventories (Tables)	3 Months Ended
	Mar. 31, 2014
Inventories	'
Schedule of inventories	'
	Inventories consisted of the following (in thousands):
		March 31,			December 31,
		2014			2013
	Finished goods	$	29,285		$	28,400
	Raw materials and packaging	9,724			7,896
	Allowances for obsolescence	(2,380		)	(2,253		)
		$	36,629		$	34,043

Fair_Value_Measurement_of_Asse1

Fair Value Measurement of Assets and Liabilities (Tables)	3 Months Ended
	Mar. 31, 2014
Fair Value Measurement of Assets and Liabilities	'
Schedule of carrying and fair values of the Company's long-term debt	'
	The carrying and fair values of the Company’s long-term debt were as follows (in thousands):
		March 31, 2014				December 31, 2013
		Carrying		Fair		Carrying		Fair
		Value		Value		Value		Value
	Term loan	$	276,637	$	281,953	$	285,982	$	291,000
	Senior notes	267,906		288,750		267,600		267,438

Income_taxes_Tables

Income taxes (Tables)	3 Months Ended
	Mar. 31, 2014
Income taxes	'
Schedule of Company's effective tax rate	'
		Three months ended March 31,
		2014		2013
	Effective tax rate	89.4	%	53.1	%

Segment_Data_Tables

Segment Data (Tables)	3 Months Ended
	Mar. 31, 2014
Segment Data	'
Summary of the financial performance of the Company's operating segments	'
	The following summarizes the financial performance of the Company’s operating segments (in thousands):
		Three Months Ended March 31, 2014
		North		International		Corporate			Consolidated
		America
	Net sales	$	61,567	$	18,992	$	—		$	80,559
	Earnings (loss) before income taxes	18,758		3,003		(21,060		)	701
	Capital expenditures	276		52		—			328
	Depreciation of property, plant and equipment and amortization of intangible assets	1,577		122		9,111			10,810
	Share based compensation	24		3		—			27
		Three Months Ended March 31, 2013
		North		International		Corporate			Consolidated
		America
	Net sales	$	56,614	$	17,799	$	—		$	74,413
	Earnings (loss) before income taxes	18,276		1,726		(21,081		)	(1,079		)
	Capital expenditures	793		151		—			944
	Depreciation of property plant and equipment and amortization of intangible assets	1,511		146		9,175			10,832
	Share based compensation	62		3		—			65

Financial_Information_for_the_1

Financial Information for the Company and Its Subsidiaries (Tables)	3 Months Ended
	Mar. 31, 2014
Financial Information for the Company and Its Subsidiaries	'
Schedule of Condensed Consolidating Balance Sheet	'
	March 31, 2014
		Issuer			Combined			Combined			Eliminations			Consolidated
					Guarantor			Non-
					Subsidiaries			Guarantor
								Subsidiaries
	ASSETS
	Current assets:
	Cash	$	4,789		$	—		$	8,393		$	—		$	13,182
	Accounts receivable, net	6			63,100			17,834			—			80,940
	Inventories	—			26,716			9,913			—			36,629
	Other current assets	60,487			(54,367		)	1,280			—			7,400
	Total current assets	65,282			35,449			37,420			—			138,151
	Property, plant and equipment, net	7,823			17,078			2,658			—			27,559
	Goodwill	—			310,576			46,931			—			357,507
	Intangible assets, net	—			268,916			35,982			(1,244		)	303,654
	Investment in subsidiaries	627,915			113,737			—			(741,652		)	—
	Investment in affiliate	10,000			—			—			—			10,000
	Deferred financing costs and other assets, net	3,265			87			—			—			3,352
	Total assets	$	714,285		$	745,843		$	122,991		$	(742,896	)	$	840,223
	LIABILITIES AND SHAREHOLDER’S EQUITY
	Current liabilities:
	Accounts payable	$	786		$	16,255		$	4,192		$	—		$	21,233
	Accrued expenses and other current liabilities	16,981			10,283			5,021			—			32,285
	Due to Clorox	69			23			(1		)	—			91
	Due to Parent	695			—			—			—			695
	Current portion of long-term debt, less discount	79			—			—			—			79
	Total current liabilities	18,610			26,561			9,212			—			54,383
	Long-term debt, less discount and current portion	544,464			—			—			—			544,464
	Other liability	2,500			—			—			—			2,500
	Deferred income taxes	5,121			81,367			42			—			86,530
	Total liabilities	570,695			107,928			9,254			—			687,877
	Shareholder’s equity	143,590			637,915			113,737			(742,896		)	152,346
	Total liabilities and shareholder’s equity	$	714,285		$	745,843		$	122,991		$	(742,896	)	$	840,223
	Year Ended December 31, 2013
		Issuer			Combined			Combined			Eliminations			Consolidated
					Guarantor			Non-						Total
					Subsidiaries			Guarantor
								Subsidiaries
	ASSETS
	Current assets:
	Cash	$	14,843		$	—		$	6,410		$	—		$	21,253
	Accounts receivable	78			44,885			17,247			—			62,210
	Inventory	—			24,553			9,490			—			34,043
	Other current assets	53,853			(45,072		)	1,009			—			9,790
	Total current assets	68,774			24,366			34,156			—			127,296
	Property, plant and equipment	8,061			18,037			2,838			—			28,936
	Goodwill	—			310,576			48,250			—			358,826
	Intangible assets	—			276,461			38,198			(1,189		)	313,470
	Investment in subsidiaries	647,107			115,394			—			(762,501		)	—
	Other assets	3,632			87			—			—			3,719
	Total assets	$	727,574		$	744,921		$	123,442		$	(763,690	)	$	832,247
	LIABILITIES AND SHAREHOLDER’S EQUITY
	Current liabilities:
	Accounts payable	$	169		$	5,103		$	2,856		$	—		$	8,128
	Accrued expenses and other current liabilities	10,063			8,263			5,129			—			23,455
	Due to Clorox	69			23			(1		)	—			91
	Due to Parent	745			—			—			—			745
	Notes payable, current portion	71			—			—			—			71
	Total current liabilities	11,117			13,389			7,984						32,490
	Notes payable, less current portion and discount	553,511			—			—			—			553,511
	Other liabilities	2,500			—			—			—			2,500
	Deferred income taxes	5,121			84,425			64			—			89,610
	Total liabilities	572,249			97,814			8,048			—			678,111
Shareholder’s equity	155,325			647,107			115,394			(763,690		)	154,136
Total liabilities and shareholder’s equity	$	727,574		$	744,921		$	123,442		$	(763,690	)	$	832,247
Schedule of Condensed Consolidating Statement of Comprehensive (Loss) Income	'
	Three months ended March 31, 2014
		Issuer			Combined			Combined			Eliminations			Consolidated
					Guarantor			Non-
					Subsidiaries			Guarantor
								Subsidiaries
	Net sales	$	—		$	66,428		$	20,359		$	(6,228	)	$	80,559
	Cost of products sold	—			33,765			14,117			(6,228		)	41,654
	Gross profit	—			32,663			6,242			—			38,905
	Operating expenses:
	Selling and administrative expenses	5,729			2,941			2,882			—			11,552
	Advertising costs	—			3,924			1,481			—			5,405
	Research and development costs	—			608			—			—			608
	Amortization of acquired intangible assets	—			7,545			1,566			—			9,111
	Total operating expenses	5,729			15,018			5,929			—			26,676
	Operating (loss) profit	(5,729		)	17,645			313			—			12,229
	Non-operating expenses:
	Interest expense	11,949			—			—			—			11,949
	Other expense, net	(425		)	—			4			—			(421		)
	(Loss) earnings before (benefit) provision for income taxes	(17,253		)	17,645			309			—			701
	(Benefit) provision for income taxes	(6,406		)	6,775			258			—			627
	Equity earnings (loss) of subsidiaries, net of taxes	10,921			51			—			(10,972		)	—
	Net (loss) earnings	$	74		$	10,921		$	51		$	(10,972	)	$	74
	Other comprehensive loss:
	Foreign currency translation	(1,892		)	(1,892		)	(1,892		)	3,784			(1,892		)
	Comprehensive loss	$	(1,818	)	$	9,029		$	(1,841	)	$	(7,188	)	$	(1,818	)
	Three months ended March 31, 2013
								Combined
					Combined			Non-
					Guarantor			Guarantor
		Issuer			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	Net sales	$	—		$	61,797		$	18,606		$	(5,990	)	$	74,413
	Cost of products sold	—			34,238			12,237			(5,990		)	40,485
	Gross profit	—			27,559			6,369			—			33,928
	Operating expenses:
	Selling and administrative expenses	4,300			2,742			2,561			—			9,603
	Advertising costs	—			2,099			1,474			—			3,573
	Research and development costs	—			638			—			—			638
	Amortization of acquired intangible assets	—			7,545			1,630			—			9,175
	Total operating expenses	4,300			13,024			5,665			—			22,989
	Operating (loss) profit	(4,300		)	14,535			704			—			10,939
	Non-operating expenses:
	Interest expense	11,906			—			—			—			11,906
	Other expense, net	—			4			108			—			112
	(Loss) earnings before income taxes	(16,206		)	14,531			596			—			(1,079		)
	(Benefit) provision for income taxes	(6,103		)	5,373			157			—			(573		)
	Equity earnings of subsidiaries, net of taxes	9,597			439			—			(10,036		)	—
	Net (loss) earnings	$	(506	)	$	9,597		$	439		$	(10,036	)	$	(506	)
	Other comprehensive (loss) income:
	Foreign currency translation	(1,760		)	(1,760		)	(1,760		)	3,520			(1,760		)
	Comprehensive (loss) income	$	(2,266	)	$	7,837		$	(1,321	)	$	(6,516	)	$	(2,266	)
Schedule of Condensed Consolidating Statement of Cash Flows	'
	Three months ended March 31, 2014
		Issuer			Combined			Combined			Eliminations			Consolidated
					Guarantor			Non-
					Subsidiaries			Guarantor
								Subsidiaries
	Cash flows from operating activities:
	Net (loss) earnings	$	74		$	10,921		$	51		$	(10,972	)	$	74
	Adjustments to reconcile net earnings to net cash provided by operating activities:
	Depreciation and amortization	1,550			8,577			1,792			—			11,919
	Share-based compensation	27			—			—			—			27
	Deferred income taxes	(16		)	(3,060		)	(22		)	—			(3,098		)
	Equity earnings of subsidiaries, net of taxes	(10,921		)	(51		)	—			10,972			—
	Other	—			—			2			—			2
	Cash effect of changes in:
	Accounts receivable, net	72			(18,215		)	(587		)	—			(18,730		)
	Inventories	—			(2,163		)	(423		)	—			(2,586		)
	Prepaid taxes	(6,432		)	9,262						—			2,830
	Other current assets	(216		)	34			(269		)	—			(451		)
	Accounts payable and accrued liabilities	7,537			13,171			1,228			—			21,936
	Intercompany and other	18,277			(18,406		)	231			—			102
	Net cash provided by operating activities:	9,952			70			2,003			—			12,025
	Cash flows from investing activities:
	Capital expenditures	(206		)	(70		)	(52		)	—			(328		)
	Acquisition, net	(10,000		)	—			—			—			(10,000		)
	Net cash used in investing activities	(10,206		)	(70		)	(52		)	—			(10,328		)
	Cash flows from financing activities:
	Principal payments on term loan	(9,750		)	—			—			—			(9,750		)
	Payment of advance from Parent	(50		)	—			—			—			(50		)
	Net cash used in by financing activities	(9,800		)	—			—			—			(9,800		)
	Effect of exchange rate changes on cash	—			—			32			—			32
	Net increase in cash	(10,054		)	—			1,983			—			(8,071		)
	Cash at beginning of period	14,843			—			6,410			—			21,253
	Cash at end of period	$	4,789		$	—		$	8,393		$	—		$	13,182
	Three months ended March 31, 2013
								Combined
					Combined			Non-
					Guarantor			Guarantor
		Issuer			Subsidiaries			Subsidiaries			Eliminations			Consolidated
	Cash flows from operating activities:
	Net (loss) earnings	$	(506	)	$	9,597		$	439		$	(10,036	)	$	(506	)
	Adjustments:
	Depreciation and amortization	1,493			8,593			1,797			—			11,883
	Share-based compensation	65			—			—			—			65
	Deferred income taxes	—			(3,648		)	316			—			(3,332		)
	Equity earnings of subsidiaries, net of taxes	(9,597		)	(439		)	—			10,036			—
	Cash effect of changes in:
	Accounts receivable	34			(8,225		)	2,328			—			(5,863		)
	Inventories	—			(2,200		)	(733		)	—			(2,933		)
	Prepaid taxes	1,940			—			82			—			2,022
	Other current assets	485			(2,391		)	60			—			(1,846		)
	Accounts payable and accrued liabilities	3,964			7,682			(2,859		)	—			8,787
	Due from Clorox	—			—			(31		)	—			(31		)
	Intercompany and other	3,637			(8,176		)	4,490			—			(49		)
	Net cash (used in) provided by operating activities	1,515			793			5,889			—			8,197
	Cash flows from investing activities:
	Capital expenditures	—			(793		)	(151		)	—			(944		)
	Net cash used in investing activities	—			(793		)	(151		)	—			(944		)
	Cash flows from financing activities:
	Principal payments on term loan	(750		)	—			—			—			(750		)
	Net cash provided by financing activities	(750		)	—			—			—			(750		)
	Effect of exchange rate on cash							1						1
	Net increase (decrease) in cash	765			—			5,739			—			6,504
	Cash at beginning of period	1,477			—			2,729			—			4,206
Cash at end of period	$	2,242		$	—		$	8,468		$	—		$	10,710

The_Company_and_Summary_of_Sig2

The Company and Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended
	Mar. 31, 2014
	item
The Company and Summary of Significant Accounting Policies	'
Number of most recognizable brands held	2
Number of countries in which the entity has distributor relationships	50
Goodwill and Intangible Assets	'
Decrease in goodwill related to preliminary allocation of purchase price for an acquisition	$1,300,000
Income Taxes	'
Goodwill expected to be deductible for tax purposes	$0

Inventories_Details

Inventories (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Inventories	'	'
Finished goods	$29,285	$28,400
Raw materials and packaging	9,724	7,896
Allowances for obsolescence	-2,380	-2,253
Inventory, net	$36,629	$34,043

Fair_Value_Measurement_of_Asse2

Fair Value Measurement of Assets and Liabilities (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Carrying Value	'	'
Fair Value Measurement of Assets and Liabilities	'	'
Term loan	$276,637	$285,982
Senior notes	267,906	267,600
Fair Value	'	'
Fair Value Measurement of Assets and Liabilities	'	'
Term loan	281,953	291,000
Senior notes	$288,750	$267,438

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (Potential contract claim, Clorox, USD $)	Mar. 31, 2014	Dec. 31, 2013
Potential contract claim | Clorox	'	'
Litigation and Other Legal Matters	'	'
Percentage of first $5,000,000 in settlement costs agreed to be indemnified and reimbursed	50.00%	'
Settlement costs as basis for determining settlement costs related to the contract claim to be indemnified and reimbursed	$5,000,000	'
Accrued long-term liabilities related to loss contingency	$2,500,000	$2,500,000

Income_taxes_Details

Income taxes (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Income taxes	'	'
Effective tax rate (as a percent)	89.40%	53.10%
Discrete tax charge	$0.40	'

Segment_Data_Details

Segment Data (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
	item
Segment Data	'	'
Number of geographic segments	2	'
Segment Data	'	'
Net sales	$80,559	$74,413
Earnings (loss) before income taxes	701	-1,079
Capital expenditures	328	944
Depreciation and amortization	10,810	10,832
Share based compensation	27	65
Operating segment | North America	'	'
Segment Data	'	'
Net sales	61,567	56,614
Earnings (loss) before income taxes	18,758	18,276
Capital expenditures	276	793
Depreciation and amortization	1,577	1,511
Share based compensation	24	62
Operating segment | International	'	'
Segment Data	'	'
Net sales	18,992	17,799
Earnings (loss) before income taxes	3,003	1,726
Capital expenditures	52	151
Depreciation and amortization	122	146
Share based compensation	3	3
Corporate	'	'
Segment Data	'	'
Earnings (loss) before income taxes	-21,060	-21,081
Depreciation and amortization	$9,111	$9,175

Financial_Information_for_the_2

Financial Information for the Company and Its Subsidiaries (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Current assets:	'	'	'	'
Cash	$13,182	$21,253	$10,710	$4,206
Accounts receivable, net	80,940	62,210	'	'
Inventories	36,629	34,043	'	'
Other current assets	7,400	9,790	'	'
Total current assets	138,151	127,296	'	'
Property, plant and equipment	27,559	28,936	'	'
Goodwill	357,507	358,826	'	'
Intangible assets, net	303,654	313,470	'	'
Investment in affiliate	10,000	'	'	'
Deferred financing costs and other assets, net	3,352	3,719	'	'
Total assets	840,223	832,247	'	'
Current liabilities:	'	'	'	'
Accounts payable	21,233	8,128	'	'
Accrued expenses and other current liabilities	32,285	23,455	'	'
Current portion of long-term debt, less discount	79	71	'	'
Total current liabilities	54,383	32,490	'	'
Long-term debt, less discount and current portion	544,464	553,511	'	'
Other liability	2,500	2,500	'	'
Deferred income taxes	86,530	89,610	'	'
Total liabilities	687,877	678,111	'	'
Shareholder's equity	152,346	154,136	'	'
Total liabilities and shareholder's equity	840,223	832,247	'	'
Clorox	'	'	'	'
Current liabilities:	'	'	'	'
Due to Parent	91	91	'	'
Parent	'	'	'	'
Current liabilities:	'	'	'	'
Due to Parent	695	745	'	'
Reportable legal entities | Issuer	'	'	'	'
Current assets:	'	'	'	'
Cash	4,789	14,843	2,242	1,477
Accounts receivable, net	6	78	'	'
Other current assets	60,487	53,853	'	'
Total current assets	65,282	68,774	'	'
Property, plant and equipment	7,823	8,061	'	'
Investment in subsidiaries	627,915	647,107	'	'
Investment in affiliate	10,000	'	'	'
Deferred financing costs and other assets, net	3,265	3,632	'	'
Total assets	714,285	727,574	'	'
Current liabilities:	'	'	'	'
Accounts payable	786	169	'	'
Accrued expenses and other current liabilities	16,981	10,063	'	'
Current portion of long-term debt, less discount	79	71	'	'
Total current liabilities	18,610	11,117	'	'
Long-term debt, less discount and current portion	544,464	553,511	'	'
Other liability	2,500	2,500	'	'
Deferred income taxes	5,121	5,121	'	'
Total liabilities	570,695	572,249	'	'
Shareholder's equity	143,590	155,325	'	'
Total liabilities and shareholder's equity	714,285	727,574	'	'
Reportable legal entities | Issuer | Clorox	'	'	'	'
Current liabilities:	'	'	'	'
Due to Parent	69	69	'	'
Reportable legal entities | Issuer | Parent	'	'	'	'
Current liabilities:	'	'	'	'
Due to Parent	695	745	'	'
Reportable legal entities | Combined Guarantor Subsidiaries	'	'	'	'
Current assets:	'	'	'	'
Accounts receivable, net	63,100	44,885	'	'
Inventories	26,716	24,553	'	'
Other current assets	-54,367	-45,072	'	'
Total current assets	35,449	24,366	'	'
Property, plant and equipment	17,078	18,037	'	'
Goodwill	310,576	310,576	'	'
Intangible assets, net	268,916	276,461	'	'
Investment in subsidiaries	113,737	115,394	'	'
Deferred financing costs and other assets, net	87	87	'	'
Total assets	745,843	744,921	'	'
Current liabilities:	'	'	'	'
Accounts payable	16,255	5,103	'	'
Accrued expenses and other current liabilities	10,283	8,263	'	'
Total current liabilities	26,561	13,389	'	'
Deferred income taxes	81,367	84,425	'	'
Total liabilities	107,928	97,814	'	'
Shareholder's equity	637,915	647,107	'	'
Total liabilities and shareholder's equity	745,843	744,921	'	'
Reportable legal entities | Combined Guarantor Subsidiaries | Clorox	'	'	'	'
Current liabilities:	'	'	'	'
Due to Parent	23	23	'	'
Reportable legal entities | Combined Non-Guarantor Subsidiaries	'	'	'	'
Current assets:	'	'	'	'
Cash	8,393	6,410	8,468	2,729
Accounts receivable, net	17,834	17,247	'	'
Inventories	9,913	9,490	'	'
Other current assets	1,280	1,009	'	'
Total current assets	37,420	34,156	'	'
Property, plant and equipment	2,658	2,838	'	'
Goodwill	46,931	48,250	'	'
Intangible assets, net	35,982	38,198	'	'
Total assets	122,991	123,442	'	'
Current liabilities:	'	'	'	'
Accounts payable	4,192	2,856	'	'
Accrued expenses and other current liabilities	5,021	5,129	'	'
Total current liabilities	9,212	7,984	'	'
Deferred income taxes	42	64	'	'
Total liabilities	9,254	8,048	'	'
Shareholder's equity	113,737	115,394	'	'
Total liabilities and shareholder's equity	122,991	123,442	'	'
Reportable legal entities | Combined Non-Guarantor Subsidiaries | Clorox	'	'	'	'
Current liabilities:	'	'	'	'
Due to Parent	-1	-1	'	'
Eliminations	'	'	'	'
Current assets:	'	'	'	'
Intangible assets, net	-1,244	-1,189	'	'
Investment in subsidiaries	-741,652	-762,501	'	'
Total assets	-742,896	-763,690	'	'
Current liabilities:	'	'	'	'
Shareholder's equity	-742,896	-763,690	'	'
Total liabilities and shareholder's equity	($742,896)	($763,690)	'	'

Financial_Information_for_the_3

Financial Information for the Company and Its Subsidiaries (Details 2) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Condensed Consolidating Statement of Comprehensive Income (Loss)	'	'
Net sales	$80,559	$74,413
Cost of products sold	41,654	40,485
Gross profit	38,905	33,928
Operating expenses:	'	'
Selling and administrative expenses	11,552	9,603
Advertising costs	5,405	3,573
Research and development costs	608	638
Amortization of acquired intangible assets	9,111	9,175
Total operating expenses	26,676	22,989
Operating (loss) profit	12,229	10,939
Non-operating expenses (income)	'	'
Interest expense	11,949	11,906
Other expense, net	-421	112
Income (loss) before benefit for income taxes	701	-1,079
(Benefit) provision for income taxes	627	573
Net income (loss)	74	-506
Other comprehensive (loss) income:	'	'
Foreign currency translation	-1,892	-1,760
Comprehensive loss	-1,818	-2,266
Reportable legal entities | Issuer	'	'
Operating expenses:	'	'
Selling and administrative expenses	5,729	4,300
Total operating expenses	5,729	4,300
Operating (loss) profit	-5,729	-4,300
Non-operating expenses (income)	'	'
Interest expense	11,949	11,906
Other expense, net	-425	'
Income (loss) before benefit for income taxes	-17,253	-16,206
(Benefit) provision for income taxes	-6,406	-6,103
Equity earnings (loss) of subsidiaries, net of taxes	10,921	9,597
Net income (loss)	74	-506
Other comprehensive (loss) income:	'	'
Foreign currency translation	-1,892	-1,760
Comprehensive loss	-1,818	-2,266
Reportable legal entities | Combined Guarantor Subsidiaries	'	'
Condensed Consolidating Statement of Comprehensive Income (Loss)	'	'
Net sales	66,428	61,797
Cost of products sold	33,765	34,238
Gross profit	32,663	27,559
Operating expenses:	'	'
Selling and administrative expenses	2,941	2,742
Advertising costs	3,924	2,099
Research and development costs	608	638
Amortization of acquired intangible assets	7,545	7,545
Total operating expenses	15,018	13,024
Operating (loss) profit	17,645	14,535
Non-operating expenses (income)	'	'
Other expense, net	'	4
Income (loss) before benefit for income taxes	17,645	14,531
(Benefit) provision for income taxes	6,775	5,373
Equity earnings (loss) of subsidiaries, net of taxes	51	439
Net income (loss)	10,921	9,597
Other comprehensive (loss) income:	'	'
Foreign currency translation	-1,892	-1,760
Comprehensive loss	9,029	7,837
Reportable legal entities | Combined Non-Guarantor Subsidiaries	'	'
Condensed Consolidating Statement of Comprehensive Income (Loss)	'	'
Net sales	20,359	18,606
Cost of products sold	14,117	12,237
Gross profit	6,242	6,369
Operating expenses:	'	'
Selling and administrative expenses	2,882	2,561
Advertising costs	1,481	1,474
Amortization of acquired intangible assets	1,566	1,630
Total operating expenses	5,929	5,665
Operating (loss) profit	313	704
Non-operating expenses (income)	'	'
Other expense, net	4	108
Income (loss) before benefit for income taxes	309	596
(Benefit) provision for income taxes	258	157
Net income (loss)	51	439
Other comprehensive (loss) income:	'	'
Foreign currency translation	-1,892	-1,760
Comprehensive loss	-1,841	1,321
Eliminations	'	'
Condensed Consolidating Statement of Comprehensive Income (Loss)	'	'
Net sales	-6,228	-5,990
Cost of products sold	-6,228	-5,990
Non-operating expenses (income)	'	'
Equity earnings (loss) of subsidiaries, net of taxes	-10,972	-10,036
Net income (loss)	-10,972	-10,036
Other comprehensive (loss) income:	'	'
Foreign currency translation	3,784	3,520
Comprehensive loss	($7,188)	($6,516)

Financial_Information_for_the_4

Financial Information for the Company and Its Subsidiaries (Details 3) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:	'	'
Net (loss) earnings	$74	($506)
Adjustments to reconcile net earnings to net cash provided by operating activities:	'	'
Depreciation and amortization	11,919	11,883
Share-based compensation	27	65
Deferred income taxes	-3,098	-3,332
Other	2	'
Cash effect of changes in:	'	'
Accounts receivable, net	-18,730	-5,863
Inventories	-2,586	-2,933
Prepaid taxes	2,830	2,022
Other current assets	-451	-1,846
Accounts payable and accrued liabilities	21,936	8,787
Due from Clorox	'	-31
Intercompany and other	102	-49
Net cash provided by operating activities	12,025	8,197
Cash flows from investing activities:	'	'
Capital expenditures	-328	-944
Acquisition, net	-10,000	'
Net cash used in investing activities	-10,328	-944
Cash flows from financing activities:	'	'
Principal payments on term loan	-9,750	-750
Payment of advance from Parent	-50	'
Net cash used in financing activities	-9,800	-750
Effect of exchange rate changes on cash	32	1
Net increase (decrease) in cash	-8,071	6,504
Cash at beginning of period	21,253	4,206
Cash at end of period	13,182	10,710
Reportable legal entities | Issuer	'	'
Cash flows from operating activities:	'	'
Net (loss) earnings	74	-506
Adjustments to reconcile net earnings to net cash provided by operating activities:	'	'
Depreciation and amortization	1,550	1,493
Share-based compensation	27	65
Deferred income taxes	-16	'
Equity earnings of subsidiaries, net of taxes	-10,921	-9,597
Cash effect of changes in:	'	'
Accounts receivable, net	72	34
Prepaid taxes	-6,432	1,940
Other current assets	-216	485
Accounts payable and accrued liabilities	7,537	3,964
Intercompany and other	18,277	3,637
Net cash provided by operating activities	9,952	1,515
Cash flows from investing activities:	'	'
Capital expenditures	-206	'
Acquisition, net	-10,000	'
Net cash used in investing activities	-10,206	'
Cash flows from financing activities:	'	'
Principal payments on term loan	-9,750	-750
Payment of advance from Parent	-50	'
Net cash used in financing activities	-9,800	-750
Net increase (decrease) in cash	-10,054	765
Cash at beginning of period	14,843	1,477
Cash at end of period	4,789	2,242
Reportable legal entities | Combined Guarantor Subsidiaries	'	'
Cash flows from operating activities:	'	'
Net (loss) earnings	10,921	9,597
Adjustments to reconcile net earnings to net cash provided by operating activities:	'	'
Depreciation and amortization	8,577	8,593
Deferred income taxes	-3,060	-3,648
Equity earnings of subsidiaries, net of taxes	-51	-439
Cash effect of changes in:	'	'
Accounts receivable, net	-18,215	-8,225
Inventories	-2,163	-2,200
Prepaid taxes	9,262	'
Other current assets	34	-2,391
Accounts payable and accrued liabilities	13,171	7,682
Intercompany and other	-18,406	-8,176
Net cash provided by operating activities	70	793
Cash flows from investing activities:	'	'
Capital expenditures	-70	-793
Net cash used in investing activities	-70	-793
Reportable legal entities | Combined Non-Guarantor Subsidiaries	'	'
Cash flows from operating activities:	'	'
Net (loss) earnings	51	439
Adjustments to reconcile net earnings to net cash provided by operating activities:	'	'
Depreciation and amortization	1,792	1,797
Deferred income taxes	-22	316
Other	2	'
Cash effect of changes in:	'	'
Accounts receivable, net	-587	2,328
Inventories	-423	-733
Prepaid taxes	'	82
Other current assets	-269	60
Accounts payable and accrued liabilities	1,228	-2,859
Due from Clorox	'	-31
Intercompany and other	231	4,490
Net cash provided by operating activities	2,003	5,889
Cash flows from investing activities:	'	'
Capital expenditures	-52	-151
Net cash used in investing activities	-52	-151
Cash flows from financing activities:	'	'
Effect of exchange rate changes on cash	32	1
Net increase (decrease) in cash	1,983	5,739
Cash at beginning of period	6,410	2,729
Cash at end of period	8,393	8,468
Eliminations	'	'
Cash flows from operating activities:	'	'
Net (loss) earnings	-10,972	-10,036
Adjustments to reconcile net earnings to net cash provided by operating activities:	'	'
Equity earnings of subsidiaries, net of taxes	$10,972	$10,036

Investment_in_Affiliate_Detail

Investment in Affiliate (Details) (IDQ, USD $)	0 Months Ended
In Millions, unless otherwise specified	Mar. 17, 2014
Investment in Affiliate	'
Amount of non-controlling equity interest acquired	$10
Transaction costs	1.2
Board member	'
Investment in Affiliate	'
Transaction costs	$0.30